Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 252241 - 252260 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01FF05) atezolizumab | TECENTRIQ C/S.SOL.IN 1200MG/VIAL (20ML) 1 VIAL x 20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FF05) atezolizumab | TECENTRIQ C/S.SOL.IN 840MG/VIAL (14ML) 1 VIAL x 14ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FF06) cemiplimab | LIBTAYO C/S.SOL.IN 350MG/VIAL BTx1 vial x7 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | REGENERONIRELANDDESIGNATEDACTIVITYCOMPANY(DAC),IRELAND |
| Greece | (L01FF07) dostarlimab | JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GLAXOSMITHKLINE(IRELAND)LIMITED,IRELAND |
| Greece | (L01FG01) bevacizumab | ALYMSYS C/S.SOL.IN 25MG/ML VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL,SPAIN |
| Greece | (L01FG01) bevacizumab | ALYMSYS C/S.SOL.IN 25MG/ML VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL,SPAIN |
| Greece | (L01FG01) bevacizumab | AVASTIN C/S.SOL.IN 100 MG/4 ML BT x 1 VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FG01) bevacizumab | AVASTIN C/S.SOL.IN 400 MG/16 ML BT x 1 VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FG01) bevacizumab | MVASI® C/S.SOL.IN 25MG/ML 1 VIAL x 16ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGYIRELAND,DUBLIN,IRELAND |
| Greece | (L01FG01) bevacizumab | MVASI® C/S.SOL.IN 25MG/ML 1 VIAL x 4ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGYIRELAND,DUBLIN,IRELAND |
| Greece | (L01FG01) bevacizumab | OYAVAS C/S.SOL.IN 25MG/ML 1 VIAL x 4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L01FG01) bevacizumab | OYAVAS C/S.SOL.IN 25MG/ML VIAL x 16 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L01FG01) bevacizumab | VEGZELMA C/S.SOL.IN 25MG/ML BT X 1 VIAL X 16ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
| Greece | (L01FG01) bevacizumab | VEGZELMA C/S.SOL.IN 25MG/ML BT X 1 VIAL X 4ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
| Greece | (L01FG01) bevacizumab | ZIRABEV C/S.SOL.IN 25MG/ML BT x 1 VIALx16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FG01) bevacizumab | ZIRABEV C/S.SOL.IN 25MG/ML BT x 1 VIALx4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FG02) ramucirumab | CYRAMZA C/S.SOL.IN 10MG/ML BTx2 VIAL x10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | ELILILLYNEDERLANDB.V.,THENEDERLANDS |
| Greece | (L01FX12) tafasitamab | MINJUVI PD.C.S.INF 200MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | INCYTEBIOSCIENCESDISTRIBUTIONB.V.,THENETHERLANDS |
| Greece | (L01FX13) enfortumab vedotin | PADCEV PD.C.S.INF 20MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | ASTELLASPHARMAEUROPEB.V.,LEIDEN,NETHERLANDS |
| Greece | (L01FX13) enfortumab vedotin | PADCEV PD.C.S.INF 30MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | ASTELLASPHARMAEUROPEB.V.,LEIDEN,NETHERLANDS |
Pages
